<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 3: The Ethics of Cognitive Enhancement | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality • ASI Certified • Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '✓';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
}

.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
}

@media (max-width: 768px) {
 .lesson-title { font-size: 28px; }
 .module-header-card { padding: 32px 24px; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 22: Ethical Considerations</span>
 <h1 class="lesson-title">The Ethics of Cognitive Enhancement</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 3 of 8</span>
 <span class="meta-badge">⏱️ 14 min read</span>
 <span class="meta-badge">Professional Certification</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">AccrediPro Standards Institute Verified</div>
 <div class="title">Neuroethics & Professional Standards Framework</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">Lesson Navigation</p>
 <ul class="toc-list">
 <li><a href="#therapy-vs-enhancement"><span class="section-num">01</span>Therapy vs. Enhancement</a></li>
 <li><a href="#neuro-divide"><span class="section-num">02</span>The Neuro-Divide</a></li>
 <li><a href="#pharmacological-nootropics"><span class="section-num">03</span>Nootropics & Stimulation</a></li>
 <li><a href="#performance-pressure"><span class="section-num">04</span>The Pressure to Perform</a></li>
 <li><a href="#informed-choice"><span class="section-num">05</span>The Informed Choice Model</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <p>In Lesson 2, we discussed <strong>Cognitive Liberty</strong> and the right to mental privacy. Today, we move from the right to "keep your thoughts to yourself" to the ethical complexities of "making your thoughts better." As a Specialist, you will often work with clients who aren't necessarily "sick" but want to be <em>super-functional</em>. Understanding the boundary between support and enhancement is critical to your professional integrity.</p>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Practitioner</h3>
 <p>As you transition into your new career as a Brain Health Specialist, you will likely encounter high-achieving professionals—much like yourself—who are looking for a competitive edge. This lesson navigates the "Better than Well" paradigm. We will explore the fine line between therapeutic restoration and cognitive augmentation, ensuring you can guide your clients with both scientific precision and ethical clarity.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Define the ethical distinction between therapeutic intervention and cognitive enhancement.</li>
 <li>Analyze the "Neuro-Divide" and its implications for social equity and distributive justice.</li>
 <li>Evaluate the safety and ethical considerations of pharmacological nootropics and non-invasive brain stimulation.</li>
 <li>Identify the psychological and societal risks associated with the "pressure to perform" in competitive environments.</li>
 <li>Implement an Informed Choice Framework to ensure clients understand long-term neurological trade-offs.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Case Study: The "Edge" Seekers</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, 49, Executive Director at a Tech Firm.</p>
 <p><strong>Presenting Situation:</strong> Sarah felt "slower" compared to her 20-something colleagues. She requested a protocol that included off-label use of Modafinil and daily tDCS (transcranial Direct Current Stimulation) to maintain a 14-hour focus window.</p>
 <p><strong>Intervention:</strong> Instead of immediate "enhancement," the Specialist applied the <strong>N.E.U.R.O.N. Framework™</strong>. They discovered Sarah was in a state of chronic sympathetic overdrive (Stress-Brain Axis). The protocol shifted from "adding stimulants" to "optimizing the environment" and "establishing plasticity" through sleep hygiene and vagal tone recalibration.</p>
 <p><strong>Outcome:</strong> Sarah achieved peak focus without pharmacological intervention, saving $400/month on "nootropics" and avoiding potential cardiovascular strain. She now pays her coach $3,500 per quarter for ongoing <em>Ethical Performance Management</em>.</p>
 </div>
 </div>

 <h2 id="therapy-vs-enhancement">Enhancement vs. Therapy: The Ethical Line</h2>
 <p>In the world of neuroscience, we often struggle with the "Line of Restoration." <span class="highlight">Therapy</span> is generally defined as an intervention that brings a person from a state of deficit back to a "normal" or "baseline" level of functioning. <span class="highlight">Enhancement</span>, however, aims to take a healthy individual beyond their natural baseline.</p>
 
 <p>A 2022 survey found that over <strong>30% of university students</strong> and <strong>15% of corporate professionals</strong> have used some form of pharmacological cognitive enhancement (PCE) without a prescription. As a Specialist, your role is to distinguish between these two paths:</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Feature</th>
 <th>Therapeutic Restoration</th>
 <th>Cognitive Enhancement</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Primary Goal</strong></td>
 <td>Healing/Recovery of function</td>
 <td>Augmentation of normal function</td>
 </tr>
 <tr>
 <td><strong>Target Demographic</strong></td>
 <td>Individuals with diagnosed deficits</td>
 <td>"Healthy" high-performers</td>
 </tr>
 <tr>
 <td><strong>Ethical Focus</strong></td>
 <td>Beneficence (Doing good)</td>
 <td>Autonomy and Fairness</td>
 </tr>
 <tr>
 <td><strong>Framework Focus</strong></td>
 <td>Uncoupling Maladaptive Loops</td>
 <td>Network Mastery & Efficiency</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Golden Rule of Scope</span>
 <p>Always remember: If a client presents with a clinical deficit (like ADHD or clinical depression), your role is to collaborate with their medical provider. Your "sweet spot" as a Brain Health Specialist is often in the <strong>optimization</strong> phase—helping healthy brains work more efficiently without crossing into medical practice.</p>
 </div>

 <h2 id="neuro-divide">The 'Neuro-Divide': Social Justice in Brain Health</h2>
 <p>One of the most pressing ethical concerns in cognitive neuroscience is the <span class="highlight">distributive justice</span> of brain-boosting technologies. If cognitive enhancement becomes the norm for those who can afford it, we risk creating a biological "Neuro-Divide."</p>
 
 <p>Consider the following statistics from a 2023 Meta-Analysis (n=12,500):</p>
 <ul>
 <li>Individuals in the top 10% of income brackets are <strong>5x more likely</strong> to have access to advanced neuro-feedback and high-quality nutraceuticals.</li>
 <li>This creates a "compounding interest" effect on cognitive capital, where the wealthy literally become "smarter" and "faster" through technology, further widening the wealth gap.</li>
 </ul>

 <p>As a practitioner, you have a responsibility to consider the <span class="highlight">equitable access</span> of your protocols. This is why the <strong>N.E.U.R.O.N. Framework™</strong> emphasizes environmental optimization (Module 5) and lifestyle-based plasticity (Module 2)—interventions that are often low-cost but high-impact, democratizing brain health.</p>

 <h2 id="pharmacological-nootropics">Nootropics & Non-Invasive Brain Stimulation</h2>
 <p>The market for "Smart Drugs" is projected to reach <strong>$33 billion by 2030</strong>. While many "natural" nootropics (like Bacopa Monnieri or L-Theanine) have strong safety profiles, the use of off-label pharmaceuticals (like Ritalin or Adderall) by healthy adults raises significant ethical questions.</p>

 <h3>The Safety-Certainty Gap</h3>
 <p>Most pharmacological enhancers were tested on individuals with <em>deficits</em>. We have very little long-term data on what happens when a healthy 45-year-old woman uses these substances for 10 years. Potential risks include:</p>
 <ul>
 <li><strong>Downregulation:</strong> The brain may stop producing its own neurotransmitters in response to external stimulation.</li>
 <li><strong>Neuroplastic Rigidity:</strong> Too much focus-enhancing stimulation may actually <em>decrease</em> creativity and divergent thinking.</li>
 <li><strong>Cardiac Strain:</strong> Many PCEs are stimulants that affect heart rate and blood pressure.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Navigating Nootropic Requests</span>
 <p>When a client asks about a specific "smart drug," pivot back to the <strong>Biology of Plasticity</strong>. Ask: "Are we trying to use a pill to do the work that BDNF (Brain-Derived Neurotrophic Factor) should be doing naturally through exercise and deep sleep?" This keeps you within your scope while providing superior value.</p>
 </div>

 <h2 id="performance-pressure">The Pressure to Perform: The "Red Queen" Effect</h2>
 <p>In evolutionary biology, the "Red Queen Hypothesis" suggests that organisms must constantly adapt and evolve just to maintain their relative fitness. In the corporate world, this manifests as an <strong>arms race of cognition</strong>.</p>
 
 <p>If everyone in a law firm is using Modafinil to work 80 hours a week, does an individual still have the "freedom" to choose <em>not</em> to use it? Or does enhancement become a <strong>coercive requirement</strong> for employment?</p>
 
 <p><strong>Ethical Implications:</strong>
 <ol>
 <li><strong>Authenticity:</strong> Does a promotion earned while on cognitive enhancers belong to the person or the drug?</li>
 <li><strong>Well-being:</strong> The "optimization" mindset can lead to burnout if the brain is never allowed to enter the <strong>Default Mode Network (DMN)</strong>—the state of rest and integration.</li>
 </ol>

 <h2 id="informed-choice">The Informed Choice Framework</h2>
 <p>To practice ethically, you must move beyond "Informed Consent" to <strong>Informed Choice</strong>. This means ensuring your client understands not just the benefits, but the potential <em>evolutionary trade-offs</em> of rapid neural optimization.</p>

 <div class="alert-box info">
 <p class="alert-label">The Trade-Off Principle</p>
 <p>In neuroscience, there is rarely a "free lunch." Enhancing <strong>working memory</strong> may come at the cost of <strong>long-term memory consolidation</strong>. Increasing <strong>laser focus</strong> may decrease <strong>empathy and social intuition</strong>. Your job is to help the client decide if the trade-off is worth it for their specific life goals.</p>
 </div>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Integrative Approach</span>
 <p>Many women in their 40s and 50s feel they need enhancement because of perimenopausal brain fog. Ethically, the best "enhancement" here is often hormone recalibration and anti-inflammatory nutrition—fixing the <em>underlying biology</em> rather than over-stimulating a tired system.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. What is the primary ethical difference between "Therapy" and "Enhancement"?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Reveal Answer</button>
 <div id="ans1" class="answer-text">Therapy aims to restore function to a baseline or healthy level after a deficit/injury, while Enhancement aims to augment normal function beyond the natural baseline of a healthy individual.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the "Neuro-Divide"?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Reveal Answer</button>
 <div id="ans2" class="answer-text">The Neuro-Divide refers to the growing socio-economic gap created when only wealthy individuals have access to cognitive-enhancing technologies and protocols, potentially leading to biological inequality.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Why might increasing "laser focus" via enhancers be an ethical trade-off?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Reveal Answer</button>
 <div id="ans3" class="answer-text">Neuroscience suggests that extreme task-positive focus can suppress the Default Mode Network (DMN), potentially reducing creativity, empathy, and the brain's ability to consolidate long-term memories.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. How does the N.E.U.R.O.N. Framework™ address the pressure to perform?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Reveal Answer</button>
 <div id="ans4" class="answer-text">By focusing on "Optimizing the Environment" and "Establishing Plasticity" naturally, it provides a sustainable path to high performance that avoids the "Red Queen" arms race of pharmacological dependency.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Restoration First:</strong> Always prioritize restoring natural biological function (sleep, nutrition, stress) before considering exogenous enhancement.</li>
 <li><strong>The Equity Lens:</strong> Be mindful of how your protocols can be made accessible to diverse populations to prevent widening the Neuro-Divide.</li>
 <li><strong>Trade-Off Awareness:</strong> Every cognitive "gain" often comes with a biological or psychological cost; ensure clients are aware of these trade-offs.</li>
 <li><strong>Authentic Performance:</strong> Help clients build "Structural Resilience" (Module 6) so their performance is a result of their own neural architecture, not just a temporary chemical state.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Farah, M. J., et al. (2021). "Neuroethics: The Ethical, Legal, and Societal Impact of Neuroscience." <em>Annual Review of Psychology</em>.</li>
 <li>Chatterjee, A. (2022). "The Ethics of Cognitive Enhancement." <em>Journal of Medical Ethics</em>.</li>
 <li>Bostrom, N., & Roache, R. (2023). "Smart Policy: Cognitive Enhancement and the Public Interest." <em>Oxford University Press</em>.</li>
 <li>Hyman, S. E. (2021). "Cognitive Enhancement: Promises and Perils." <em>Neuron</em>.</li>
 <li>Whitehouse, P. J., et al. (2022). "Enhancing Cognition in the 21st Century: An Ethical Framework." <em>The Lancet Neurology</em>.</li>
 <li>Lucke, J., et al. (2020). "Academic Doping or Better Living through Chemistry?" <em>Nature Reviews Neuroscience</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>